文献速递神经肿瘤

手术切除联合近距离放射治疗作为复发高级别脑膜瘤的挽救治疗:一项匹配队列研究

Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
PubMed 文献 · J Neurooncol · 2019-11-19

单中心回顾性分析2012至2018年27例既往外照射治疗已穷尽的复发高级别脑膜瘤患者,行计划性全切除联合近距离放射粒子植入,并与同期未接受近距离放射治疗的匹配队列比较。术后并发症总体相当,但近距离放射治疗组放射性坏死发生率更高。

要点

  • 复发高级别脑膜瘤外照射穷尽后,计划性全切除联合近距离放射治疗可改善无进展生存期。
  • 近距离放射治疗组PFS-6为92.3%、PFS-12为84.6%。
  • 总生存两组无统计学显著差异,近距离放射治疗组放射性坏死发生率更高。

核心结论

  • 计划性全切除联合近距离放射治疗改善了既往外照射治疗已穷尽的复发高级别脑膜瘤患者的无进展生存期。
  • 作者认为未来改进近距离放射治疗剂量递送方法与技术可能继续延长控制率并改善这一困难患者群体的结局。

研究设计与样本

  • 单中心回顾性研究,回顾本机构2012至2018年近距离放射粒子植入的经验。
  • 共评估27例,所有患者均接受过既往放射治疗并接受计划性全切除手术。
  • 采用同期未接受近距离放射治疗的匹配队列作为对照组。
  • 主要结局为无进展生存期,次要结局包括总生存期和并发症。

主要发现

  • PFS-6为92.3%,PFS-12为84.6%。
  • 术后总体并发症两组相当,但近距离放射治疗组放射性坏死发生率更高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate surgical resection with brachytherapy placement as a salvage treatment in patients with recurrent high-grade meningioma who exhausted prior external beam treatment options. METHODS: Single-center retrospective review of our institutional experience of brachytherapy implantation from 2012 to 2018. The primary outcome of the study was progression free survival (PFS). Secondary outcomes included overall survival (OS) and complications. A matched cohort of patients not treated with brachytherapy over the same time period was evaluated as a control group. All patients had received prior radiation treatment and underwent planned gross total resection (GTR) surgery. RESULTS: A total of 27 cases were evaluated. Compared with prior treatment, brachytherapy implantation demonstrated a statistically significant improvement in tumor control [HR 0.316 (0.101 - 0.991), p = 0.034]. PFS-6 and PFS-12 were 92.3% and 84.6%, respectively. Compared with the matched control cohort, brachytherapy treatment demonstrated improved PFS [HR 0.310 (0.103 - 0.933), p = 0.030]. Overall survival was not statistically significantly different between groups [HR 0.381 (0.073 - 1.982), p = 0.227]. Overall postoperative complications were comparable between groups, although there was a higher incidence of radiation necrosis in the brachytherapy cohort. CONCLUSION: Brachytherapy with planned GTR improved PFS in recurrent high-grade meningioma patients who exhausted prior external beam radiation treatment options. Future improvement of brachytherapy dose delivery methods and techniques may continue to prolong control rates and improve outcomes for this challenging group of patients.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Mooney MA, Bi WL, Cantalino JM, et al. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. J Neurooncol. 2019. PMID: 31745706. doi:10.1007/s11060-019-03342-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。